UK markets closed

Sanofi (SAN.PA)

Paris - Paris Delayed price. Currency in EUR
Add to watchlist
90.00+0.84 (+0.94%)
At close: 05:35PM CEST
Full screen
Previous close89.16
Open89.57
Bid0.00 x 0
Ask0.00 x 0
Day's range88.54 - 90.25
52-week range80.60 - 104.32
Volume1,267,158
Avg. volume1,408,166
Market cap112.473B
Beta (5Y monthly)0.44
PE ratio (TTM)24.93
EPS (TTM)3.61
Earnings date25 Jul 2024
Forward dividend & yield3.76 (4.22%)
Ex-dividend date13 May 2024
1y target est106.70
  • Zacks

    Sanofi (SNY) Signs Deal for AI-Powered Drug Development

    Sanofi (SNY) inks collaboration deal with Formation Bio and OpenAI to build AI-powered software to advance drug development and create new medicines.

  • Benzinga

    ChatGPT Parent Open AI Partners With Sanofi, Formation Bio To Boost AI-Driven Drug Development

    Tuesday, French drugmaker Sanofi SA (NASDAQ:SNY) announced its collaboration with OpenAI and Formation Bio to accelerate drug development projects. Also Read: Drugmaker Sanofi’s Strong Dupixent And Beyfortus Vaccine Sales Propel Q1 Earnings. Sanofi said the partnership with OpenAI will allow it to access proprietary data to develop AI models for its biopharma models, while Formation Bio will provide additional engineering resources. The three teams will combine data, software, and tuned models t

  • GlobeNewswire

    Press Release: Sanofi, Formation Bio and OpenAI announce first-in-class AI collaboration

    Sanofi, Formation Bio and OpenAI announce first-in-class AI collaboration Paris, New York, N.Y., and San Francisco, CA, May 21, 2024. Sanofi, Formation Bio and OpenAI are collaborating to build AI-powered software to accelerate drug development and bring new medicines to patients more efficiently. The three teams will bring together data, software and tuned models to develop custom, purpose-built solutions across the drug development lifecycle. This represents a first collaboration of its kind w